Filtered By:
Drug: Lithium
Countries: New Zealand Health
This page shows you your search results in order of date.
Order by Relevance | Date
Total 22 results found since Jan 2013.
Preliminary results from the Australian Genetics of Bipolar Disorder Study: A nation-wide cohort
CONCLUSION: Our findings highlight the high rate of comorbidities and adverse drug reactions among adults living with bipolar disorder in the general Australian population. Future genomic analyses focus on identifying genetic variants influencing pharmacotherapy treatment response and side effects.PMID:37655588 | DOI:10.1177/00048674231195571
Source: The Australian and New Zealand Journal of Psychiatry - September 1, 2023 Category: Psychiatry Authors: Penelope A Lind Dan J Siskind Ian B Hickie Luc ía Colodro-Conde Simone Cross Richard Parker Nicholas G Martin Sarah E Medland Source Type: research
Letter to the Editor regarding 'Lithium plus antipsychotics or anticonvulsants for bipolar disorder: Comparing clinical response and metabolic changes'
Aust N Z J Psychiatry. 2023 May 6:48674231170568. doi: 10.1177/00048674231170568. Online ahead of print.NO ABSTRACTPMID:37148128 | DOI:10.1177/00048674231170568
Source: The Australian and New Zealand Journal of Psychiatry - May 6, 2023 Category: Psychiatry Authors: Medhir Kumawat Andrew Giam Prashant Tibrewal Source Type: research
Monitoring of cutaneous manifestations of lithium treatment in mental health inpatients
Aust N Z J Psychiatry. 2022 Apr 18:48674221089566. doi: 10.1177/00048674221089566. Online ahead of print.NO ABSTRACTPMID:35437024 | DOI:10.1177/00048674221089566
Source: The Australian and New Zealand Journal of Psychiatry - April 19, 2022 Category: Psychiatry Authors: Charlotte Cox Manoj George Source Type: research
